MedPath

MYLAN-CANDESARTAN HCTZ

MYLAN-CANDESARTAN HCTZ

Discontinued
DIN Number

02374897

Drug Class

Human

Market Date

Sep 24, 2012

Company
HC

Mylan Pharmaceuticals ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02374897
AIG Number0244181001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09DA06 CANDERSARTAN AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification40:28.20
Health Canada Classification

ACTIVE INGREDIENTS (2)

CANDESARTAN CILEXETILActive
Strength: 16.0 MG
Monograph: CANDESARTAN CILEXETIL
HYDROCHLOROTHIAZIDEActive
Strength: 12.5 MG
Monograph: HYDROCHLOROTHIAZIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.